(Q66861478)
Statements
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia (English)
O'Connell MJ
S. C. Schimpff
C. A. Schiffer
J. L. Lichtenfeld
J. Aisner
M. J. O'Connell